Identification of a seasonal influenza vaccine–induced broadly protective neuraminidase antibody

Seasonal influenza viruses cause significant global illness and death annually, and the potential spillover of avian H5N1 poses a serious pandemic threat. Traditional influenza vaccines target the variable hemagglutinin (HA) protein, necessitating annual vaccine updates, while the slower-evolving neuraminidase (NA) presents a promising target for broader protection. We investigated the breadth of anti-NA B cell responses to seasonal influenza vaccination in humans. We screened plasmablast-derived monoclonal antibodies (mAbs) from three donors, identifying 11 clonally distinct NA mAbs from 268 vaccine-specific mAbs. Among these, mAb-297 showed exceptionally broad NA inhibition, effectively protecting mice against lethal doses of influenza A and B viruses, including H5N1. We show that mAb-297 targets a common binding motif in the conserved NA active site. Our findings show that while B cell responses against NA following conventional, egg-derived influenza vaccines are rare, inducing broadly protective NA antibodies through such vaccination remains feasible, highlighting the importance of improving NA immunogens to develop a more broadly protective influenza vaccine.

Authors

Institutions

Publication Details

Journal
The Journal of Experimental Medicine
Published
2025-04-03
DOI
https://doi.org/10.1084/jem.20241930
Citations
5
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
6.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of a seasonal influenza vaccine–induced broadly protective neuraminidase antibody

Hanover Matz, Tossapol Pholcharee, Anders Madsen, Ali H. Ellebedy et al.
5 citations
The Journal of Experimental Medicine
Influenza Virus Research Studies
6.77
article

Identification of a seasonal influenza vaccine–induced broadly protective neuraminidase antibody

Hanover Matz, Tossapol Pholcharee, Anders Madsen, Ali H. Ellebedy, Fangjie Han, Nicholas C. Wu, Julian Q. Zhou, Sameer Kumar Malladi, Stephen Horváth, Aaron J. Schmitz, Jackson S. Turner, Nisreen M.A. Okba, Florian Krammer, Huibin Lv, Maria Ibanez Trullen
article en
5 citations

Abstract

Seasonal influenza viruses cause significant global illness and death annually, and the potential spillover of avian H5N1 poses a serious pandemic threat. Traditional influenza vaccines target the variable hemagglutinin (HA) protein, necessitating annual vaccine updates, while the slower-evolving neuraminidase (NA) presents a promising target for broader protection. We investigated the breadth of anti-NA B cell responses to seasonal influenza vaccination in humans. We screened plasmablast-derived monoclonal antibodies (mAbs) from three donors, identifying 11 clonally distinct NA mAbs from 268 vaccine-specific mAbs. Among these, mAb-297 showed exceptionally broad NA inhibition, effectively protecting mice against lethal doses of influenza A and B viruses, including H5N1. We show that mAb-297 targets a common binding motif in the conserved NA active site. Our findings show that while B cell responses against NA following conventional, egg-derived influenza vaccines are rare, inducing broadly protective NA antibodies through such vaccination remains feasible, highlighting the importance of improving NA immunogens to develop a more broadly protective influenza vaccine.

The Journal of Experimental MedicineVol. 222(6)
Semmelweis University (HU), University of Illinois Urbana-Champaign (US), Illinois College (US), Washington University in St. Louis (US), Haukeland University Hospital (NO), University of Bergen (NO), Medical University of Vienna (AT), Icahn School of Medicine at Mount Sinai (US)
Howard Hughes Medical Institute, Purdue University, Alvin J. Siteman Cancer Center, Moderna, National Institutes of Health, University of Illinois at Urbana-Champaign, National Cancer Institute, National Institute of Allergy and Infectious Diseases, Division of Materials Research
Good health and well-being
Openalex Percentile: Top 3%
Influenza Virus Research Studies
6.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.